Rakesh Adhikari

Featured in: Favicon

tandfonline.com Favicon

onlinelibrary.wiley.com

Articles

A Trivalent Protein-Based Pan-Betacoronavirus Vaccine Elicits Cross-Neutralizing Antibodies Against a Panel of Coronavirus Pseudoviruses

1 month ago | digitalcommons.library.tmc.edu | Syamala Rani Thimmiraju |Rakesh Adhikari |JeAnna R. Redd |Maria Villar

To view the content in your browser, please download Adobe Reader or, alternately, you may Download the file to your hard drive. NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2

1 month ago | digitalcommons.library.tmc.edu | Syamala Rani Thimmiraju |Rakesh Adhikari |Maria Villar |Jungsoon Lee

Keywordsimmune escape, vaccine efficacy, COVID-19, SARS-CoV-2Abstract(1) Background: We previously reported the development of a recombinant protein SARS-CoV-2 vaccine, consisting of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, adjuvanted with aluminum hydroxide (alum) and CpG oligonucleotides.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →